Abstract
Silicon (Si) deficiency in animals results in bone defects. Choline-stabilized orthosilicic acid (ch-OSA) was found to have a high bioavailability compared to other Si supplements. The effect of ch-OSA supplementation was investigated on bone loss in aged ovariectomized (OVX) rats. Female Wistar rats (n = 58, age 9 months) were randomized in three groups. One group was sham-operated (sham, n = 21), and bilateral OVX was performed in the other two groups. OVX rats were supplemented orally with ch-OSA over 30 weeks (OVX1, n = 20; 1 mg Si/kg body weight daily) or used as controls (OVX0, n = 17). The serum Si concentration and the 24-hour urinary Si excretion of supplemented OVX rats was significantly higher compared to sham and OVX controls. Supplementation with ch-OSA significantly but partially reversed the decrease in Ca excretion, which was observed after OVX. The increase in bone turnover in OVX rats tended to be reduced by ch-OSA supplementation. ch-OSA supplementation increased significantly the femoral bone mineral content (BMC) in the distal region and total femoral BMC in OVX rats, whereas lumbar BMC was marginally increased. Femoral BMD was significantly increased at two sites in the distal region in OVX rats supplemented with ch-OSA compared to OVX controls. Total lumbar bone mineral density was marginally increased by ch-OSA supplementation. In conclusion, ch-OSA supplementation partially prevents femoral bone loss in the aged OVX rat model.
Similar content being viewed by others
References
Raisz LG (2005) Clinical practice. Screening for osteoporosis. N Engl J Med. 353:164–171
Rosen CJ (2005) Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 353:595–603
Robins SP, News SA (1997) Markers of bone turnover in relation to bone health. Proc Nutr Soc 56:903–914
Marie PJ (2005) Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos Int 16(suppl 1):S7–S10
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441
Lau KH, Baylink DJ (1998) Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 13:1660–1667
Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H (1995) Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 24:303–307
Saltman PD, Strause LG (1993) The role of trace elements in osteoporosis. J Am Coll Nutr 12:384–389
Carlisle EM (1970) Silicon: a possible factor in bone calcification. Science 167:279–280
Carlisle EM (1976) In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr 106:478–484
Schwarz K, Milne DB (1972) Growth-promoting effects of silicon in rats. Nature 239:333–334
Seaborn CD, Nielsen FH (1994) Dietary silicon affects acid and alkaline phosphatase and 45calcium uptake in bone of rats. J Trace Elem Exp Med 7:11–18
Seaborn CD, Nielsen FH (2002) Dietary silicon and arginine affects mineral element composition of rat femur and vertebra. Biol Trace Elem Res 89:239–250
Keeting PE, Oursler MJ, Wiegand KE, Bonde SK, Spelsberg TC, Riggs BL (1992) Zeolite A increases proliferation, differentiation, and transforming growth factor production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 7:1281–1289
Schütze N, Oursler MJ, Nolan J, Riggs BL, Spelsberg TC (1995) Zeolite A inhibits osteoclast-mediated bone resorption in vitro. J Cell Biochem 58:39–46
Jugdaohsingh R, Tucker KL, Qiao N, Cupples LA, Kiel DP, Powell JJ (2004) Dietary silicon intake is positively associated with bone mineral density in men and pre-menopausal women of the Framingham offspring cohort. J Bone Miner Res 19:297–307
Reffitt DM, Jugdaohsingh R, Thompson RP, Powell JJ (1999) Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. J Inorg Biochem 76:141–147
Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, Powell JJ, Hampson GN (2003) Orthosilicic acid stimulates collagen type I synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32:127–135
Calomme M, Cos P, D’Haese P, Vingerhoets R, Lamberts L, De Broe M, Van Hoorebeke C, Vanden Berghe D (2000) Silicon absorption from stabilized orthosilicic acid and other supplements in healthy subjects. In: Roussel AM, Anderson RA, Favier AE (eds) Trace Elements in Man and Animals, vol 10. Kluwer Academic/Plenum Publishers, pp 1111–1114
Calomme MR, Vanden Berghe DA (1997) Supplementation of calves with stabilized orthosilicic acid. Effect on the Si, Ca, Mg, and P concentrations in serum and the collagen concentration in skin and cartilage. Biol Trace Elem Res 56:153–165
Calomme MR, Wijnen P, Sindambiwe JB, Cos P, Mertens J, Geusens P, Vanden Berghe DA (2002) Effect of choline stabilized orthosilicic acid on bone density in chicks. Calcif Tissue Int 70:292
Barel A, Calomme M, Timchenko A, De Paepe K, Demeester N, Rogiers V, Clarys P, Vanden Berghe D (2005) Effect of oral intake of choline stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res 297:147–153
Jiang Y, Zhao J, Genant HK, Dequecker J, Geusens P (1997) Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats. J Bone Miner Res 12:820–831
Hott M, de Pollak C, Modrowski D, Marie PJ (1993) Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int 53:174–179
Rico H, Gallego-Lago JL, Hernandez ER, Villa LF, Sanchez-Atrio A, Seco C, Gervas JJ (2000) Effect of silicon supplement on osteopenia induced by ovariectomy in rats. Calcif Tissue Int 66:53–55
Nielsen FH, Poellot R (2004) Dietary silicon affects bone turnover differently in ovariectomized and sham-operated growing rats. J Trace Elem Exp Med 17:137–149
Van Dyck K, Van Cauwenbergh R, Robberecht H, Deelstra H (1999) Bioavailability of silicon from food and food supplements. Fresenius J Anal Chem 363:541–544
Aerssens J, Van Audekercke R, Geusens P, Schot LP, Osman AA, Dequecker J (1993) Mechanical properties, bone mineral content, and bone composition of the rat femur: influence of ovariectomy and nandrolone decanoate treatment. Calcif Tissue Int 53:269–277
Spector TD, Calomme MR, Anderson S, Swaminathan R, Jugdaohsingh R, Vanden Berghe D, Powell JJ (2005) Effect on bone turnover and BMD of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomized, placebo-controlled trial. J Bone Miner Res 20(suppl 1):S172
Wasserman RH, Fullmer CS (1995) Vitamin D and intestinal Ca transport: facts, speculations and hypotheses. J Nutr 125(suppl 7):1971S–1979S
Rabon HW, Roland DA, Bryant MM, Smith RC, Barnes DG, Laurent SM (1995) Absorption of silicon and aluminium by hens fed sodium zeolite A with various levels of dietary cholecalciferol. Poult Sci 74:352–359
Acknowledgement
ch-OSA was developed by Dirk Vanden Berghe for Bio Minerals n.v. This study was supported by a grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, project 000290).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calomme, M., Geusens, P., Demeester, N. et al. Partial Prevention of Long-Term Femoral Bone Loss in Aged Ovariectomized Rats Supplemented with Choline-Stabilized Orthosilicic Acid. Calcif Tissue Int 78, 227–232 (2006). https://doi.org/10.1007/s00223-005-0288-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-005-0288-0